We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 37

Anti-corruption digest - June 2013
  • Dorsey & Whitney LLP
  • Global, United Kingdom, USA
  • June 21 2013

French oil and gas giant Total SA has entered into a three-year deferred prosecution agreement ("DPA") with the U.S. Department of Justice ("DOJ") to


Former Innospec Inc executive charged
  • Dorsey & Whitney LLP
  • United Kingdom, USA
  • November 18 2011

Former Innospec Inc executive, Dr David Turner, was charged at a London court for allegedly bribing Iraqi and Indonesian officials between 2002 and 2008 to secure government contracts


Anti-corruption digest
  • Dorsey & Whitney LLP
  • Global, USA
  • September 17 2012

Canadian-based Nordion, Inc. has indicated to US and Canadian regulators that it may have uncovered possible violations of the FCPA and the corresponding Canadian anti-corruption statute, the Canadian Corruption of Foreign Public Officials Act. Nordion, based in Ottawa, supplies medical isotopes and had revenue of $274 million in the US in 2011


Fraud-on-the-market
  • Dorsey & Whitney LLP
  • USA
  • July 19 2012

On June 11, 2012, the US Supreme Court granted certiorari to hear Amgen Inc. v. Connecticut Retirement Plans & Trust Funds, a case involving two questions that could have a substantial impact on securities class actions


SEC investigating Bristol-Myers Squibb
  • Dorsey & Whitney LLP
  • USA
  • May 17 2012

Bristol-Myers Squibb has confirmed that the SEC is investigating its sales and marketing practices in various countries


Biomet Inc.
  • Dorsey & Whitney LLP
  • USA
  • April 16 2012

Medical device company Biomet has agreed to pay more than $22 million to settle charges by the Securities and Exchange Commission (SEC) as well as parallel criminal charges by the U.S. Department of Justice (DOJ


Layne Christensen Company
  • Dorsey & Whitney LLP
  • USA
  • June 24 2011

Layne Christensen is another company facing an investigation by a law firm that represents shareholders in class actions against publicly traded companies


Sovereign wealth funds
  • Dorsey & Whitney LLP
  • USA
  • February 22 2011

Sources are claiming that the SEC is investigating whether banks and private equity firms have violated the FCPA in dealings with sovereign wealth funds


The UK’s Bribery Act of 2010: the obligations and risks it imposes on US employers with business in the UK
  • Dorsey & Whitney LLP
  • United Kingdom, USA
  • February 21 2011

The UK Bribery Act is expected to come into force shortly


RINO International Corporation
  • Dorsey & Whitney LLP
  • USA
  • February 22 2011

RINO International Corporation ("RINO"), a Nevada corporation with all of its operating subsidiaries and affiliates based in China, recently disclosed in a filing with the SEC that it is the subject of a formal investigation by the SEC, including with respect to Foreign Corrupt Practices Act ("FCPA") compliance